Analyst price target range
Harmony Biosciences Holdings Price Target: $47.64 Average
Direct answer
Harmony Biosciences Holdings's average price target is $47.64.
The verified analyst range runs from $30.00 to $70.00.
The low target implies -24.3%, the high target implies +76.6%, and the range spans 100.9% of the current price.
Forecast evidence checked October 3, 2026.
Get free Harmony Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $39.64
- Average price target
- $47.64
- High price target
- $70.00
- Low price target
- $30.00
- Low target gap
- -24.3%
- Target upside
- +20.2%
- High target gap
- +76.6%
- Target range width
- 100.9%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- October 3, 2026
- Valid through
- October 10, 2026
Explore related company data
Read the frequently asked questions.
What is Harmony Biosciences Holdings's average price target?
Harmony Biosciences Holdings's verified average price target is $47.64. The target range is $30.00 to $70.00.
How far are Harmony Biosciences Holdings's low and high targets from the recorded price?
The low target implies -24.3%, while the high target implies +76.6%.
How many analysts are included in Harmony Biosciences Holdings's consensus?
The verified consensus includes 11 analysts.
How is Harmony Biosciences Holdings's target upside or downside calculated?
The average target of $47.64 is divided by the recorded price of $39.64, then one is subtracted to produce +20.2%. This does not guarantee a future return.
When was Harmony Biosciences Holdings's analyst forecast verified?
The data was verified on 2026-10-03. The dataset is valid through 2026-10-10.